Is there a need for distal protection during native vessel percutaneous coronary intervention in patients with stable coronary artery disease?

Journal of Cardiovascular Medicine

Volumn 15, Issue 2, 2014, Pages 170-172

  Hildebrandt, Heike A ^a   Kahlert, Philipp ^a   Baars, Theodor ^a,b   Kleinbongard, Petra ^b   Erbel, Raimund ^a   Heusch, Gerd ^b  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; TROPONIN I;

ADULT; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; CASE REPORT; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; ELECTROCARDIOGRAPHY MONITORING; EMBOLIC PROTECTION DEVICE; HUMAN; INTRAVASCULAR ULTRASOUND; LETTER; MALE; MIDDLE AGED; OPTICAL COHERENCE TOMOGRAPHY; PERCUTANEOUS CORONARY INTERVENTION; RIGHT CORONARY ARTERY;

CARDIOVASCULAR AGENTS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY STENOSIS; DRUG-ELUTING STENTS; EMBOLIC PROTECTION DEVICES; EMBOLISM; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; PATIENT SELECTION; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE OF TESTS; PROSTHESIS DESIGN; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SPECTROSCOPY, NEAR-INFRARED; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84896714613     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0b013e3283619351     Document Type: Letter

References (11)

1. Silber S, Albertsson P, Avilé s FF, et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 2005; 26:804-847.
2. Smith SC, Feldman TE, Hirshfeld JW, et al. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 2006; 113:156-175.
3. Jin B, Dong XH, Zhang C, Li Y, Shi HM. Distal protection devices in primary percutaneous coronary intervention of native coronary artery lesions: a meta-analysis of randomized controlled trials. Curr Med Res Opin 2012; 28:871-876.
4. Heusch G, Kleinbongard P, Bö se D, et al. Coronary microembolization: from bedside to bench and back to bedside. Circulation 2009; 120:1822-1836.
5. Vancraeynest D, Pasquet A, Roelants V, Gerber BL, Vanoverschelde JL. Imaging the vulnerable plaque. J Am Coll Cardiol 2011; 57:1961-1979.
6. Waxman S, Dixon SR, L'Allier P, et al. In vivo validation of a catheter-based near-infrared spectroscopy system for detection of lipid core coronary plaques: initial results of the SPECTACL study. JACC Cardiovasc Imaging 2009; 2:858-868.
7. Brilakis ES, Abdel-Karim AR, Papayannis AC, et al. Embolic protection device utilization during stenting of native coronary artery lesions with large lipid core plaques as detected by near-infrared spectroscopy. Catheter Cardiovasc Interv 2012; 80:1157-1162.
8. Kleinbongard P, Konorza T, Bö se D, et al. Lessons from human coronary aspirate. J Mol Cell Cardiol 2012; 52:890-896.
9. Baars T, Konorza T, Kahlert P, et al. Coronary aspirate TNFa reflects saphenous vein bypass graft restenosis risk in diabetic patients. Cardiovasc Diabetol 2013; 12:12.
10. Bö se D, von Birgelen C, Zhou XY, et al. Impact of atherosclerotic plaque composition on coronary microembolization during percutaneous coronary interventions. Basic Res Cardiol 2008; 103:587-597.
11. Goldstein JA, Maini B, Dixon SR, et al. Detection of lipid-core plaques by intracoronary near-infrared spectroscopy identifies high risk of periprocedural myocardial infarction. Circ Cardiovasc Interv 2011; 4:429-437.